PRF Technologies (PRFX) Assets (2019 - 2025)
PRF Technologies (PRFX) posted quarterly Assets of $12.0 million for Q4 2025, up 165.15% year-on-year from $4.5 million in Q4 2024, and up 7.49% on a QoQ basis from $11.2 million in Q2 2025.
PRF Technologies (PRFX) Assets (2019 - 2025) Analysis & Trends
PRF Technologies (PRFX) has reported Assets for 7 consecutive years, with $12.0 million the latest figure, recorded in Q4 2025.
- Quarterly Assets rose 165.15% year-over-year to $12.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.0 million (up 165.15% YoY) and the FY2025 annual result came in at $12.0 million, up 165.15% from the prior year.
- Assets climbed to $12.0 million in Q4 2025 per PRFX's latest filing, from $11.2 million in the prior quarter.
- Over the last five years, Assets for PRFX reached as high as $21.4 million in Q1 2021 and fell as low as $389000.0 in Q4 2023.
- A 5-year average of $12.2 million and a median of $12.0 million in 2025 frame the typical range for Assets.
- Annual changes were most pronounced in 2021 — Assets soared 2267.3% — and 2023, when it sank 96.84%.
- Year by year, Assets stood at $19.1 million in 2021, then slumped by 35.36% to $12.3 million in 2022, then plunged by 96.84% to $389000.0 in 2023, then soared by 1063.24% to $4.5 million in 2024, then surged by 165.15% to $12.0 million in 2025.
- According to Business Quant data, Assets over the past three periods registered $12.0 million, $11.2 million, and $4.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.40 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.04 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.15 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 98.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.71 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 69.30 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 36.83 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.91 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.22 Bn |
| 10 | PRF Technologies | 745,168.93 | 451,168.93 | - | 12.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.00 Mn |
| Jun 30, 2025 | 11.16 Mn |
| Dec 31, 2024 | 4.53 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Mar 31, 2024 | 5.37 Mn |
| Dec 31, 2023 | 389,000.00 |
| Sep 30, 2023 | 10.89 Mn |
| Jun 30, 2023 | 8.32 Mn |
| Mar 31, 2023 | 10.42 Mn |
| Dec 31, 2022 | 12.33 Mn |
| Sep 30, 2022 | 14.85 Mn |
| Jun 30, 2022 | 15.99 Mn |
| Mar 31, 2022 | 17.71 Mn |
| Dec 31, 2021 | 19.07 Mn |
| Sep 30, 2021 | 20.34 Mn |
| Jun 30, 2021 | 19.84 Mn |
| Mar 31, 2021 | 21.35 Mn |
| Dec 31, 2020 | 17.80 Mn |
| Jun 30, 2020 | 838,000.00 |
| Dec 31, 2019 | 1.16 Mn |